Related Experiment Video
Updated: May 24, 2026

Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
Quantifying hepatic steatosis - more than meets the eye
Adam P Levene1, Hiromi Kudo, Matthew J Armstrong
1Department of Histopathology, Imperial College Faculty of Medicine at St Mary's Hospital, London, UK. adamlevene@doctors.org.uk
Oil Red-O digital image analysis (ORO DIA) accurately quantifies liver steatosis, improving non-alcoholic fatty liver disease (NAFLD) scoring. This method is superior to H&E staining for assessing hepatic lipid content.
Area of Science:
- Hepatology
- Histopathology
- Medical Imaging
Background:
- Non-alcoholic fatty liver disease (NAFLD) activity score (NAS) assesses disease severity.
- Accurate quantification of steatosis is crucial for NAS scoring.
- Steatosis contributes significantly to the NAS.
Purpose of the Study:
- To determine the optimal histological technique for identifying and quantifying liver steatosis.
- To compare the accuracy of different staining and analysis methods for steatosis assessment.
- To validate findings in both mouse models and human liver biopsies.
Main Methods:
- Assessed percentage steatosis and fat droplet size using H&E and ORO staining.
- Employed light microscopy and digital image analysis (DIA) for quantification.
- Compared histological results with biochemical triglyceride content and MRI assessments.
Main Results:
- H&E staining showed poor correlation with tissue triglyceride concentration.
- ORO DIA demonstrated high sensitivity and specificity for steatosis.
- ORO DIA strongly correlated with triglyceride content in mouse and human livers (R=0.706, P=0.001; R=0.894, P=0.041).
- MRI assessment of hepatic steatosis was found to be inaccurate.
Conclusions:
- Oil Red-O digital image analysis (ORO DIA) is the most accurate method for detecting and quantifying liver steatosis.
- ORO DIA offers a more robust approach for NAS scoring compared to H&E.
- While H&E-based NAS is clinically valid, ORO DIA enhances the precision of steatosis assessment.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

